These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 22732422)
1. Pain and genetics. Fernandez Robles CR; Degnan M; Candiotti KA Curr Opin Anaesthesiol; 2012 Aug; 25(4):444-9. PubMed ID: 22732422 [TBL] [Abstract][Full Text] [Related]
2. Current evidence for a genetic modulation of the response to analgesics. Lötsch J; Geisslinger G Pain; 2006 Mar; 121(1-2):1-5. PubMed ID: 16472919 [No Abstract] [Full Text] [Related]
3. Pharmacogenetics in pain management: the clinical need. Webster LR Clin Lab Med; 2008 Dec; 28(4):569-79. PubMed ID: 19059063 [TBL] [Abstract][Full Text] [Related]
4. Effect of genetic factors on opioid action. Kosarac B; Fox AA; Collard CD Curr Opin Anaesthesiol; 2009 Aug; 22(4):476-82. PubMed ID: 19502975 [TBL] [Abstract][Full Text] [Related]
5. [Genetic polymorphisms and human sensitivity to pain and opioids]. Nishizawa D; Nagashima M; Satoh Y; Tagami M; Ikeda K Masui; 2009 Sep; 58(9):1093-101. PubMed ID: 19764431 [TBL] [Abstract][Full Text] [Related]
6. [Genetic polymorphisms and opioid therapies]. Landau R Presse Med; 2008 Oct; 37(10):1415-22. PubMed ID: 18440763 [TBL] [Abstract][Full Text] [Related]
7. Genetic factors in pain and its treatment. Stamer UM; Stüber F Curr Opin Anaesthesiol; 2007 Oct; 20(5):478-84. PubMed ID: 17873601 [TBL] [Abstract][Full Text] [Related]
8. Genetics of pain, opioids, and opioid responsiveness. Tremblay J; Hamet P Metabolism; 2010 Oct; 59 Suppl 1():S5-8. PubMed ID: 20837195 [TBL] [Abstract][Full Text] [Related]
9. Pain polymorphisms and opioids: An evidence based review. Vieira CMP; Fragoso RM; Pereira D; Medeiros R Mol Med Rep; 2019 Mar; 19(3):1423-1434. PubMed ID: 30592275 [TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics in palliative care. Kleine-Brueggeney M; Musshoff F; Stuber F; Stamer UM Forensic Sci Int; 2010 Dec; 203(1-3):63-70. PubMed ID: 20709477 [TBL] [Abstract][Full Text] [Related]
11. Contribution of genetic variants to pain susceptibility in Parkinson disease. Greenbaum L; Tegeder I; Barhum Y; Melamed E; Roditi Y; Djaldetti R Eur J Pain; 2012 Oct; 16(9):1243-50. PubMed ID: 22473870 [TBL] [Abstract][Full Text] [Related]
12. The value of CYP2D6 and OPRM1 pharmacogenetic testing for opioid therapy. Reynolds KK; Ramey-Hartung B; Jortani SA Clin Lab Med; 2008 Dec; 28(4):581-98. PubMed ID: 19059064 [TBL] [Abstract][Full Text] [Related]
13. Understanding the genetic determinants of pain and pain management. Miaskowski C Semin Oncol Nurs; 2009 May; 25(2 Suppl 1):S1-7. PubMed ID: 19447317 [TBL] [Abstract][Full Text] [Related]
14. Prediction of codeine toxicity in infants and their mothers using a novel combination of maternal genetic markers. Sistonen J; Madadi P; Ross CJ; Yazdanpanah M; Lee JW; Landsmeer ML; Nauta M; Carleton BC; Koren G; Hayden MR Clin Pharmacol Ther; 2012 Apr; 91(4):692-9. PubMed ID: 22398969 [TBL] [Abstract][Full Text] [Related]
15. Combined catechol-O-methyltransferase and mu-opioid receptor gene polymorphisms affect morphine postoperative analgesia and central side effects. Kolesnikov Y; Gabovits B; Levin A; Voiko E; Veske A Anesth Analg; 2011 Feb; 112(2):448-53. PubMed ID: 21127283 [TBL] [Abstract][Full Text] [Related]
16. Can heterogeneity of chronic sickle-cell disease pain be explained by genomics? A literature review. Adegbola MA Biol Res Nurs; 2009 Jul; 11(1):81-97. PubMed ID: 19487302 [TBL] [Abstract][Full Text] [Related]
19. A logistic equation to determine the validity of tramadol from related gene polymorphisms and psychological factors. Zhao Q; Sun J; Tao Y; Wang S; Jiang C; Zhu Y; Yu F; Zhu J Pharmacogenomics; 2014 Mar; 15(4):487-95. PubMed ID: 24624916 [TBL] [Abstract][Full Text] [Related]
20. [Implication of genetic polymorphism on neuropathic pain]. Iseki M; Sato-Takeda M Masui; 2009 Sep; 58(9):1112-21. PubMed ID: 19764434 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]